Overview

An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis

Status:
Terminated

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

This study assessed the pharmacodynamic effects of patiromer on serum potassium in participants on hemodialysis.

Phase:

Phase 2

Details

Lead Sponsor:

Relypsa, Inc.